Skip to content
Virax Biolabs

Innovating Immune Resistance Testing

  • ViraxImmune™
  • Media
  • Leadership
  • Contact
  • Investor Relations
  • ViraxImmune™
  • Media
  • Leadership
  • Contact
  • Investor Relations

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Abu Dhabi, Dubai Serve as Gateway to International Markets for Biopharma

by Lisa Munger

How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing (featuring Tomasz George)

Better Health Care Tests, Faster (featuring Tomasz George)

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Virax Biolabs readies clinical performance study of ViraxImmune Platform

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

← Previous
Next →

BioCity Glasgow
Bo’Ness Road, Newhouse
Lanarkshire
ML1 5UH
United Kingdom

Quick links

  • Discover ViraxImmune™ Novel PAIS Diagnostic Development
  • Custom Immunology Services By Virax Biolabs
  • Terms and Conditions
  • News And Media Updates From Virax Biolabs
  • Meet Virax Biolabs’ Leadership Team and Advisory Board
  • Contact
  • Investor Relations
  • Discover ViraxImmune™ Novel PAIS Diagnostic Development
  • Custom Immunology Services By Virax Biolabs
  • Terms and Conditions
  • News And Media Updates From Virax Biolabs
  • Meet Virax Biolabs’ Leadership Team and Advisory Board
  • Contact
  • Investor Relations

Subscribe to Our Newsletter

You can cancel subscription any time

Follow us

Facebook Twitter Linkedin Instagram
© All Rights Reserved, Virax Biolabs 2026 | Privacy Policy | Terms of Service